ASRM Releases First Updated Guidance on Recurrent Pregnancy Loss in Over a Decade
New committee opinion emphasizes evidence-based evaluation, targeted care, emotional support during High-Risk Pregnancy Awareness Week
June 1, 2026
For Immediate Release
WASHINGTON, DC—As High-Risk Pregnancy Awareness Week (June 1–8, 2026) begins, the American Society for Reproductive Medicine (ASRM) is highlighting recurrent pregnancy loss as a serious and often misunderstood reproductive health condition through its newly updated Practice Committee opinion, the first update on the topic since 2012. The opinion outlines a more evidence-based approach to evaluation and care.
ASRM defines recurrent pregnancy loss (RPL) as the spontaneous loss of two or more pregnancies, excluding confirmed molar or ectopic pregnancies. The updated opinion also recognizes very early pregnancy losses confirmed by blood or urine testing and clarifies that losses do not need to be consecutive to warrant evaluation.
Key recommendations from the updated opinion include:
For patients and families navigating RPL, the updated opinion offers reassurance and hope: ASRM notes that 50 to 80 percent of patients will go on to have a successful pregnancy, even without medical intervention.
High-Risk Pregnancy Awareness Week is a national campaign focused on raising awareness of conditions that can complicate pregnancy and the importance of specialized care for patients and families navigating those experiences. As the week kicks off, ASRM encourages patients, clinicians, and policymakers to continue advancing compassionate, evidence-based care for those affected.
For Immediate Release
WASHINGTON, DC—As High-Risk Pregnancy Awareness Week (June 1–8, 2026) begins, the American Society for Reproductive Medicine (ASRM) is highlighting recurrent pregnancy loss as a serious and often misunderstood reproductive health condition through its newly updated Practice Committee opinion, the first update on the topic since 2012. The opinion outlines a more evidence-based approach to evaluation and care.
“Recurrent pregnancy loss can be medically complex, emotionally devastating, and deeply isolating for patients and families,” said Robert E. Brannigan, MD, President of ASRM. “This updated guidance reflects ASRM’s commitment to ensuring that patients receive care grounded in the best available science, delivered with compassion, and focused on what is most likely to help. Patients experiencing recurrent pregnancy loss deserve answers, support, and care that is guided by evidence.”
ASRM defines recurrent pregnancy loss (RPL) as the spontaneous loss of two or more pregnancies, excluding confirmed molar or ectopic pregnancies. The updated opinion also recognizes very early pregnancy losses confirmed by blood or urine testing and clarifies that losses do not need to be consecutive to warrant evaluation.
Key recommendations from the updated opinion include:
- Chromosome testing of miscarriage tissue, when possible, as a first step in evaluation
- More targeted testing and evaluation based on a patient’s history and risk factors
- Screening for conditions such as thyroid disease and diabetes when appropriate
- Avoiding routine use of tests and treatments that lack strong evidence of benefit
- Greater emphasis on emotional support and counseling for patients and couples
For patients and families navigating RPL, the updated opinion offers reassurance and hope: ASRM notes that 50 to 80 percent of patients will go on to have a successful pregnancy, even without medical intervention.
High-Risk Pregnancy Awareness Week is a national campaign focused on raising awareness of conditions that can complicate pregnancy and the importance of specialized care for patients and families navigating those experiences. As the week kicks off, ASRM encourages patients, clinicians, and policymakers to continue advancing compassionate, evidence-based care for those affected.
Fertility in the News
Policy Update from the ASRM Office of Public Affairs: SART Membership Now Mandatory in Tennessee
ASRM-backed Tennessee law makes SART membership mandatory for ART clinic certification, strengthening fertility care standards and oversight.
ASRM Releases First Updated Guidance on Recurrent Pregnancy Loss in Over a Decade
ASRM updates recurrent pregnancy loss guidance with evidence-based evaluation, targeted care, and emotional support during High-Risk Pregnancy Week.Find a Health Professional
Connect with reproductive medicine experts who will guide you through your unique journey. Our search tool allows personalized matches based on location, specialization, and expertise. Take control of your reproductive health with compassionate providers, innovative treatments, and unwavering support.
Search for an Expert